A nonclonal outbreak of vancomycin-sensitive


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 6 8 2019
medline: 30 5 2020
entrez: 6 8 2019
Statut: ppublish

Résumé

To describe an outbreak of bacteremia caused by vancomycin-sensitive Enterococcus faecalis (VSEfe). An investigation by retrospective case control and molecular typing by whole-genome sequencing (WGS). A tertiary-care neonatal unit in Melbourne, Australia. Risk factors for 30 consecutive neonates with VSEfe bacteremia from June 2011 to December 2014 were analyzed using a case control study. Controls were neonates matched for gestational age, birth weight, and year of birth. Isolates were typed using WGS, and multilocus sequence typing (MLST) was determined. Bacteremia for case patients occurred at a median time after delivery of 23.5 days (interquartile range, 14.9-35.8). Previous described risk factors for nosocomial bacteremia did not contribute to excess risk for VSEfe. WGS typing results designated 43% ST179 as well as 14 other sequence types, indicating a polyclonal outbreak. A multimodal intervention that included education, insertion checklists, guidelines on maintenance and access of central lines, adjustments to the late onset sepsis antibiotic treatment, and the introduction of diaper bags for disposal of soiled diapers after being handled inside the bed, led to termination of the outbreak. Typing using WGS identified this outbreak as predominately nonclonal and therefore not due to cross transmission. A multimodal approach was then sought to reduce the incidence of VSEfe bacteremia.

Identifiants

pubmed: 31379308
pii: S0899823X19002022
doi: 10.1017/ice.2019.202
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1116-1122

Auteurs

Despina Kotsanas (D)

Monash Infectious Diseases, Monash Medical Centre, Clayton, Victoria, Australia.

Kenneth Tan (K)

Monash Newborn, Monash Children's Hospital, Clayton, Victoria, Australia.
Department of Paediatrics, Monash University, Clayton, Victoria, Australia.

Carmel Scott (C)

Infection Control, Monash Medical Centre, Clayton, Victoria, Australia.

Britta Baade (B)

Monash Newborn, Monash Children's Hospital, Clayton, Victoria, Australia.

Michaela Hui Ling Cheng (MHL)

Department of Paediatrics, Monash University, Clayton, Victoria, Australia.

Zien Vanessa Tan (ZV)

Department of Paediatrics, Monash University, Clayton, Victoria, Australia.

Jacqueline E Taylor (JE)

Monash Newborn, Monash Children's Hospital, Clayton, Victoria, Australia.

Jason C Kwong (JC)

Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia.

Torsten Seemann (T)

Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia.

Geoffrey W Coombs (GW)

Antimicrobial Resistance and Infectious Diseases (AMRID) Research Laboratory, Murdoch University, Murdoch, Western Australia, Australia.

Benjamin P Howden (BP)

Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia.

Rhonda L Stuart (RL)

Monash Infectious Diseases, Monash Medical Centre, Clayton, Victoria, Australia.
Department of Medicine, Monash University, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH